BEDFORD, MA--(Marketwire - September 30, 2009) - Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, today announced it has been recognized by The Boston Business Journal as one of the fastest-growing public companies in Massachusetts. The rankings were published in the September 18-24, 2009 edition of The Boston Business Journal.

"We are proud to be recognized by The Boston Business Journal as Massachusetts' second fastest-growing public company," said Duane DeSisto, President and Chief Executive Officer at Insulet. "Insulet's impressive growth over the last few years demonstrates the tremendous appeal of the easy-to-use OmniPod System. We remain focused on expanding the market opportunities for our innovative product, while advancing our mission to improve the lives of people living with diabetes."

The Boston Business Journal's rankings of the fastest-growing public companies were based on revenue growth from 2006 through 2008. During this period, Insulet experienced 884% in revenue growth. Additionally, Insulet was ranked as the company with the third largest one-year increase in revenue.

About the OmniPod Insulin Management System

The OmniPod Insulin Management System is the world's only tubing-free insulin pump. OmniPod offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease. OmniPod has just two components: the small, discreet, watertight Pod, worn almost anywhere on the body to hold and deliver insulin; and the PDM (Personal Diabetes Manager), a hand-held device that communicates wirelessly to program the Pod, calculates suggested doses and has a built-in FreeStyle® blood glucose meter.

For more information on OmniPod, visit

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

Contact Information: Media Contacts: Erich Sandoval Lazar Partners 917-497-2867 Darcy Keane Lazar Partners 646-871-8487